SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Venus Remedies Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

526953

INE411B01019

515.9180123

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VENUSREM

24.25

2407.73

EPS(TTM)

Face Value()

Div & Yield %

74.29

0.56

Back

sylph technologies ltd

Hikal reports consolidated net loss of Rs 5.90 crore in the December 2025 quarter

Feb 11,2026

Net loss of Hikal reported to Rs 5.90 crore in the quarter ended December 2025 as against net profit of Rs 17.20 crore during the previous quarter ended December 2024. Sales rose 11.80% to Rs 490.70 crore in the quarter ended December 2025 as against Rs 438.90 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	490.70	438.90	12
OPM %	16.85	16.43	-
PBDT	70.00	57.00	23
PBT	28.80	23.80	21
NP	-5.90	17.20	PL

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)